Skip to main content
. 2020 Oct 11;21(20):7481. doi: 10.3390/ijms21207481

Figure 1.

Figure 1

Axial images of a positron emission tomography (PET) scan performed with 18F-Florbetaben (a,b), 18F-Fluorodeoxyglucose (c,d), and MRI (e,f) in a patient with suspected AD. The images show pathological amyloid burden in the cortex, while a significant reduction in cortical glucose consumption is visible in the left parietal (c, arrow) and temporal lobes (d, arrow). MRI does not show any abnormal findings.